References
- 1
Al-Housni MB, Hutchings F, Dalby M. et al .
Does myocardial perfusion scintigraphy predict improvement in symptoms and exercise
capacity following successful elective percutaneous coronary intervention?.
J Nucl Cardiol.
2009;
16
869-877
- 2
Bastarrika G, Lee YS, Huda W. et al .
CT of coronary artery disease.
Radiology.
2009;
253
317-338
- 3
Boden WE, O’Rourke RA, Teo KK. et al .
Optimal medical therapy with or without PCI for stable coronary disease.
N Engl J Med.
2007;
356
1503-1516
- 4
Falk E, Shah PK, Fuster V.
Coronary plaque disruption.
Circulation.
1995;
92
657-671
- 5
Fazel R, Krumholz HM, Wang Y. et al .
Exposure to low-dose ionizing radiation from medical imaging procedures.
N Engl J Med.
2009;
361
849-857
- 6
Gaemperli O, Husmann L, Schepis T. et al .
Coronary CT angiography and myocardial perfusion imaging to detect flow-limiting stenoses:
a potential gatekeeper for coronary revascularization?.
Eur Heart J.
2009;
30
2921-2929
- 7
Hachamovitch R, Berman DS, Shaw LJ. et al .
Incremental prognostic value of myocardial perfusion single photon emission computed
tomography for the prediction of cardiac death: differential stratification for risk
of cardiac death and myocardial infarction.
Circulation.
1998;
97
535-543
- 8
Hachamovitch R, Hayes SW, Friedman JD. et al .
Comparison of the short-term survival benefit associated with revascularization compared
with medical therapy in patients with no prior coronary artery disease undergoing
stress myocardial perfusion single photon emission computed tomography.
Circulation.
2003;
107
2900-2907
- 9
Hacker M, Jakobs T, Hack N. et al .
Sixty-four slice spiral CT angiography does not predict the functional relevance of
coronary artery stenoses in patients with stable angina.
Eur J Nucl. Med Mol Imaging.
2007;
34
4-10
- 10
Klocke FJ, Baird MG, Lorell BH. et al .
ACC/AHA/ASNC guidelines for the clinical use of cardiac radionuclide imaging – executive
summary: a report of the American College of Cardiology/American Heart Association
Task Force on Practice Guidelines (ACC/AHA/ASNC Committee to Revise the 1995 Guidelines
for the Clinical Use of Cardiac Radionuclide Imaging).
J Am Coll Cardiol.
2003;
42
1318-1333
- 11
Lindner O, Burchert W, Bengel FM. et al .
[Myocardial perfusion scintigraphy 2008 in Germany. Results of the fourth query.].
Nuklearmedizin [Internet]. 2010 März 1 [zitiert 2010 März 28];49. Available from:
http://www.ncbi.nlm.nih.gov/pubmed/20198276
- 12
Min JK, Shaw LJ, Berman DS.
The present state of coronary computed tomography angiography a process in evolution.
J Am Coll Cardiol.
2010;
55
957-965
- 13
Naghavi M, Libby P, Falk E. et al .
From vulnerable plaque to vulnerable patient: a call for new definitions and risk
assessment strategies: Part II.
Circulation.
2003;
108
1772-1778
- 14
Nandalur KR, Dwamena BA, Choudhri AF. et al .
Diagnostic performance of stress cardiac magnetic resonance imaging in the detection
of coronary artery disease: a meta-analysis.
J Am Coll Cardiol.
2007;
50
1343-1353
- 15
Pennell DJ.
Cardiovascular magnetic resonance.
Circulation.
2010;
121
692-705
- 16
Russ M, Werdan K, Cremer J. et al .
Different treatment options in chronic coronary artery disease: when is it the time
for medical treatment, percutaneous coronary intervention or aortocoronary bypass
surgery?.
Dtsch Arztebl Int.
2009;
106
253-261
- 17
Shaw LJ, Berman DS, Maron DJ. et al .
Optimal medical therapy with or without percutaneous coronary intervention to reduce
ischemic burden: results from the Clinical Outcomes Utilizing Revascularization and
Aggressive Drug Evaluation (COURAGE) trial nuclear substudy.
Circulation.
2008;
117
1283-1291
- 18
Shaw LJ, Iskandrian AE.
Prognostic value of gated myocardial perfusion SPECT.
J Nucl Cardiol.
2004;
11
171-185
- 19
Sterbefälle, Sterbeziffer, Ränge, Anteile der 10/20/50/100 häufigsten Todesursachen
(ab 1998) [Internet]. [zitiert 2010 März 17];Available from:
http://www.gbe-bund.de/oowa921-install/servlet/oowa/aw92/dboowasys921.xwdevkit/xwd_init?gbe.isgbetol/xs_start_neu/i/7786244/516/D/-/77147890
- 20 Europäische Statistik. Haupttabellen [Internet]. [zitiert 2010 März 19];Available
from: http://epp.eurostat.ec.europa.eu/portal/page/portal/health/public_health/main_tables
Korrespondenzadresse
Prof. Dr. Wolfgang Burchert
Institut für Radiologie,
Nuklearmedizin und Molekulare Bildgebung
Herz- und Diabeteszentrum Nordrhein-Westfalen
Universitätsklinik der Ruhr-Universität Bochum
Georgstraße 11
32545 Bad Oeynhausen
Telefon: +49/5731 97-1308
Fax: +49/5731 97-2190
eMail: wolfgang.burchert@rub.de
